The study was financed by the British Cardiovascular Intervention Society
, based in London, with a grant from Maquet Cardiovascular of Wayne, New Jersey, and Johnson & Johnson of New Brunswick, New Jersey. Eli Lilly & Co., based in Indianapolis, supplied medication used during the study.